1.
Bioorg Med Chem Lett
; 28(10): 1892-1896, 2018 06 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29636218
RESUMO
A novel series of EP4 agonists and antagonists have been identified, and then used to validate their potential in the treatment of inflammatory pain. This paper describes these novel ligands and their activity within a number of pre-clinical models of pain, ultimately leading to the identification of the EP4 partial agonist GSK726701A.